|
1
|
Xi J, Feng J, Li Q, Li X and Zeng S: The
long non-coding RNA lncFOXO1 suppresses growth of human breast
cancer cells through association with BAP1. Int J Oncol.
50:1663–1670. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu J, Tan M and Cai Q: The Warburg effect
in tumor progression: Mitochondrial oxidative metabolism as an
anti-metastasis mechanism. Cancer Lett. 356:156–164. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang JS, Gillies RD and Gatenby RA:
Adaptation to hypoxia and acidosis in carcinogenesis and tumor
progression. Semin Cancer Biol. 18:330–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pinheiro C, Longatto-Filho A,
Azevedo-Silva J, Casal M, Schmitt FC and Baltazar F: Role of
monocarboxylate transporters in human cancers: State of the art. J
Bioenerg Biomembr. 44:127–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Halestrap AP: The monocarboxylate
transporter family-Structure and functional characterization. IUBMB
Life. 64:1–9. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonen A, Miskovic D, Tonouchi M, Lemieux
K, Wilson MC, Marette A and Halestrap AP: Abundance and subcellular
distribution of MCT1 and MCT4 in heart and fast-twitch skeletal
muscles. Am J Physiol Endocrinol Metab. 278:E1067–E1077. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Philp NJ, Yoon H and Lombardi L: Mouse
MCT3 gene is expressed preferentially in retinal pigment and
choroid plexus epithelia. Am J Physiol Cell Physiol.
280:C1319–C1326. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doyen J, Trastour C, Ettore F, Peyrottes
I, Toussant N, Gal J, Ilc K, Roux D, Parks SK, Ferrero JM and
Pouysségur J: Expression of the hypoxia-inducible monocarboxylate
transporter MCT4 is increased in triple negative breast cancer and
correlates independently with clinical outcome. Biochem Biophys Res
Commun. 451:54–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fisel P, Kruck S, Winter S, Bedke J,
Hennenlotter J, Nies AT, Scharpf M, Fend F, Stenzl A, Schwab M and
Schaeffeler E: DNA methylation of the SLC16A3 promoter regulates
expression of the human lactate transporter MCT4 in renal cancer
with consequences for clinical outcome. Clin Cancer Res.
19:5170–5181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fisel P, Schaeffeler E and Schwab M:
Clinical and functional relevance of the monocarboxylate
transporter family in disease pathophysiology and drug therapy.
Clin Transl Sci. 11:352–364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gotanda Y, Akagi Y, Kawahara A, Kinugasa
T, Yoshida T, Ryu Y, Shiratsuchi I, Kage M and Shirouzu K:
Expression of monocarboxylate transporter (MCT)-4 in colorectal
cancer and its role: MCT4 contributes to the growth of colorectal
cancer with vascular endothelial growth factor. Anticancer Res.
33:2941–2947. 2013.PubMed/NCBI
|
|
13
|
Hao J, Chen H, Madigan MC, Cozzi PJ,
Beretov J, Xiao W, Delprado WJ, Russell PJ and Li Y: Co-expression
of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate
transporters is associated with prostate cancer drug resistance and
progression. Br J Cancer. 103:1008–1018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hemdan T, Malmstrom PU, Jahnson S and
Segersten U: Emmprin expression predicts response and survival
following cisplatin containing chemotherapy for bladder cancer: A
validation study. J Urol. 194:1575–1581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim Y, Choi JW, Lee JH and Kim YS:
Expression of lactate/H+ symporters MCT1 and MCT4 and
their chaperone CD147 predicts tumor progression in clear cell
renal cell carcinoma: Immunohistochemical and The Cancer Genome
Atlas data analyses. Hum Pathol. 46:104–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pinheiro C, Sousa B, Albergaria A, Paredes
J, Dufloth R, Vieira D, Schmitt F and Baltazar F: GLUT1 and CAIX
expression profiles in breast cancer correlate with adverse
prognostic factors and MCT1 overexpression. Histol Histopathol.
26:1279–1286. 2011.PubMed/NCBI
|
|
17
|
Szubert S, Szpurek D, Moszynski R, Nowicki
M, Frankowski A, Sajdak S and Michalak S: Extracellular matrix
metalloproteinase inducer (EMMPRIN) expression correlates
positively with active angiogenesis and negatively with basic
fibroblast growth factor expression in epithelial ovarian cancer. J
Cancer Res Clin Oncol. 140:361–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng D, Zhu X, Ding X, Zhu X, Yin Y and
Li G: Sensitive detection of CD147/EMMPRIN and its expression on
cancer cells with electrochemical technique. Talanta. 105:187–191.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu S, Chu D, Zhang Y, Wang X, Gong L, Han
X, Yao L, Lan M, Li Y and Zhang W: EMMPRIN/CD147 expression is
associated with disease-free survival of patients with colorectal
cancer. Med Oncol. 30:3692013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McClelland GB and Brooks GA: Changes in
MCT 1, MCT 4, and LDH expression are tissue specific in rats after
long-term hypobaric hypoxia. J Appl Physiol (1985). 92:1573–1584.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lokuhetty D, White VA, Watanabe R, Cree
IA, et al: WHO Classification of Tumours, 5th Edition, Volume 2:
Breast Tumours. (Lyon, France). IARC Press. 2019.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maria RM, Altei WF, Selistre-de-Araujo HS
and Colnago LA: Impact of chemotherapy on metabolic reprogramming:
Characterization of the metabolic profile of breast cancer
MDA-MB-231 cells using 1H HR-MAS NMR spectroscopy. J
Pharm Biomed Anal. 146:324–328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Long Y, Gao Z, Hu X, Xiang F, Wu Z, Zhang
J, Han X, Yin L, Qin J, Lan L, et al: Downregulation of MCT4 for
lactate exchange promotes the cytotoxicity of NK cells in breast
carcinoma. Cancer Med. 7:4690–4700. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perou CM, Sorlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kreike B, van Kouwenhove M, Horlings H,
Weigelt B, Peterse H, Bartelink H and van de Vijver MJ: Gene
expression profiling and histopathological characterization of
triple-negative/basal-like breast carcinomas. Breast Cancer Res.
9:R652007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bleach R and McIlroy M: The divergent
function of androgen receptor in breast cancer; analysis of steroid
mediators and tumor intracrinology. Front Endocrinol (Lausanne).
9:5942018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ruan Y, Zeng F, Cheng Z, Zhao X, Fu P and
Chen H: High expression of monocarboxylate transporter 4 predicts
poor prognosis in patients with lung adenocarcinoma. Oncol Lett.
14:5727–5734. 2017.PubMed/NCBI
|
|
29
|
Mathupala SP, Parajuli P and Sloan AE:
Silencing of monocarboxylate transporters via small interfering
ribonucleic acid inhibits glycolysis and induces cell death in
malignant glioma: An in vitro study. Neurosurgery. 55:1410–1419.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo F, Zou Z, Liu X, Ling M, Wang Q, Wang
Q, Lu L, Shi L, Liu Y, Liu Q and Zhang A: Enhanced glycolysis,
regulated by HIF-1α via MCT-4, promotes inflammation in
arsenite-induced carcinogenesis. Carcinogenesis. 38:615–626. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Curry J, Tassone P, Gill K, Tuluc M, BarAd
V, Mollaee M, Whitaker-Menezes D, Rodeck U, Luginbuhl A, Cognetti
D, et al: Tumor metabolism in the microenvironment of nodal
metastasis in oral squamous cell carcinoma. Otolaryngol Head Neck
Surg. 157:798–807. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yan P, Li YH, Tang ZJ, Shu X and Liu X:
High monocarboxylate transporter 4 protein expression in stromal
cells predicts adverse survival in gastric cancer. Asian Pac J
Cancer Prev. 15:8923–8929. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sanita P, Capulli M, Teti A, Galatioto GP,
Vicentini C, Chiarugi P, Bologna M and Angelucci A: Tumor-stroma
metabolic relationship based on lactate shuttle can sustain
prostate cancer progression. BMC cancer. 14:1542014. View Article : Google Scholar : PubMed/NCBI
|
